If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding the world, consider this: The pandemic has turbocharged widespread acceptance of at-home digital health solutions. Forced to function in a world of social distancing, healthcare providers and physicians have quickly discovered how easily telehealth visits, remote patient monitoring (RPM) and digital therapeutics can improve patient care. Many of these digital health innovations are designed to address
Read More
Medtronic Secures 2 CE Mark Approvals for Guardian 4 Sensor & For InPen MDI Smart Insulin Pen
What You Should Know: - Today Medtronic announced multiple CE Marks for a portfolio of diabetes products that will launch in Europe later this year. This includes InPen and Guardian 4 sensor which requires no fingersticks - . The new CE Marks also allow for this next generation sensor to be integrated with either MiniMed 780G or InPen or for stand-alone CGM use as well. InPen MDI Smart Insulin Pen The InPen is the first and only smart insulin pen approved in Europe that's
Read More
Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets
What We Should Know: - Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions. - The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen™ and
Read More
Glytec Raises $21M to Fix Hospital Insulin Management
What You Should Know: - Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management. - Glytec’s insulin management solution, eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized insulin dosing regimens, and get patients into target blood glucose range
Read More
Medtronic Launches World’s First 7-Day Wear Infusion Set to Reduce Burden for People with Diabetes
What You Should Know: - Medtronic has announced the launch of the world’s first and only infusion set that can be worn for up to seven days (instead of the typical three) in select European countries. The infusion set is responsible for delivering insulin from the pump into the body. This new infusion set is compatible with all MiniMed™ 600 and 700 series insulin pumps. - It’s recommended that typical insulin infusion sets be changed every three days, whereas the glucose sensor (which is
Read More
Medtronic Launches Initiatives to Address Health Equity for People of Color Living with Diabetes
What You Should Know: - Medtronic announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities. New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities Details of each partnership, as well as additional
Read More
Glooko Raises $30M to Expand Digital Diabetes Management Platform
What You Should Know: - Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. - Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
Yale New Haven Health Deploys Virtual Clinic for Pediatric Patients with Diabetes
What You Should Know: - After taking part in proving the clinical benefit of using AI-based decision support tools, as was recently published in Nature Medicine, Yale New Haven Health System and DreaMed Diabetes announced a collaboration that will explore what it would take to adopt such a solution into a real-world health system. - As part of the collaboration, Yale New Haven will utilize DreaMed’s Advisor Pro platform to create a virtual clinic, this real-world evaluation will assess the
Read More
Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease
Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and provider organizations that include this approach to testing. At a time when America’s hospitals and physician groups face lost revenues due to the COVID-19 pandemic, there is a pressing need for reducing costs while
Read More
Data-Driven Future: Impact of Machine Learning on Diabetes Management
“Information technology and business are becoming inextricably interwoven. I don't think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare. The ability to collect, analyze, and use data is becoming ubiquitous with many of healthcare’s most exciting advancements. Whether it’s Google’s DeepMind using artificial intelligence (AI) to help
Read More
